Cogent Biosciences Inc (COGT)

SG&A Expenses

$98.37M

TTM · Period ending: · USD

COGT logo

COGT SG&A Expenses

Latest reported$98.37M
COGT TTM SG&A Expenses ($4.68M → $98.37M)
High-resolution chart · PNG

COGT sg&a expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Cogent Biosciences Inc SG&A Expenses — Trailing twelve months (TTM) (USD)
Period endingSG&A Expenses (USD)
98,369,000
79,921,000
63,583,000
51,338,000
48,772,000
45,486,000
43,281,000
41,101,000
38,754,000
36,875,000
34,375,000
31,869,000
29,301,000
27,463,000
26,212,000
24,335,000
22,471,000
20,999,000
19,638,000
19,860,000
20,437,000
18,335,000
17,422,000
14,768,000
11,891,000
12,151,000
10,968,000
10,318,000
9,964,000
8,881,000
7,454,000
6,851,000
5,808,000
4,800,000
4,680,000
24,607,000
27,985,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.